Shop/IGF-1 LR3 1mg
IGF-1 LR3 1mg
Growth Hormone

IGF-1 LR3 1mg

4.839 reviews

IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a synthetic analog of endogenous IGF-1, engineered with an 83 amino acid sequence that includes a 13 amino acid N-terminal extension and an arginine substitution at position 3. These modifications significantly extend its half-life and potency compared to native IGF-1. Each vial contains 1mg of research-grade IGF-1 LR3.

€89per vial

Reconstitution requires bacteriostatic water (sold separately).

Volume pricing — buy more, pay less per vial

Select a tier to set the quantity. Discount is applied automatically at checkout.

  • COA with every batch

    Independent EU lab, ≥99% HPLC

  • Secure encrypted checkout

    Card payments over TLS

  • Discreet packaging

    Plain outer box, no branding

  • EU dispatch in 24–48h

    Tracked delivery

  • Cold-chain handling

    Temperature-controlled transit

About this compound

IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a recombinant analogue of endogenous IGF-1 with an N-terminal methionine extension and a glutamic acid→arginine substitution at position 3. This R3 modification reduces binding affinity to IGF-binding proteins (IGFBP-1 through -6) by over 1000-fold, extending the plasma half-life from ~12 minutes to 20–30 hours and dramatically increasing bioavailability at peripheral tissue receptors. It is the preferred research tool for studying mTOR-driven protein synthesis, muscle satellite cell biology, anti-catabolic mechanisms, and neurotrophy — independently of hepatic IGFBP sequestration.

≥99%HPLC Purity
1mgPer Vial
30+Years Researched
83 aaStructure
IGF-1 LR3 1mg research data 1IGF-1 LR3 1mg research data 2

Research Snapshot — IGF-1 LR3

Key Mechanisms & Pathways

  • PI3K → Akt → mTORC1Phosphorylates S6K1 and 4E-BP1 — the two rate-limiting steps in ribosomal biogenesis and protein translation initiation.
  • Ras → MEK → ERKDrives G1→S cell cycle progression via cyclin D1; regulates DNA replication and myoblast differentiation.
  • FOXO SuppressionAkt phosphorylates FOXO1/3a, preventing transcription of atrophy genes MuRF1 and Atrogin-1 — blocking muscle proteolysis.
  • Satellite Cell ActivationIGF-1R on muscle stem cells drives proliferation and differentiation into new myofibres — adding myonuclei.
  • IGFBP-3 BypassR3 substitution reduces IGFBP binding affinity by >1000×, extending half-life from 12 min to 20–30 hours.
  • NeurotrophyPromotes neuron survival, axonal regeneration and oligodendrocyte differentiation in CNS injury models.

Preclinical & Clinical Research Summary

Research Area Key Finding Source
Muscle Hypertrophy +25% muscle mass in 7 days via local injection in rat hindlimb — without systemic GH. Coleman ME et al., 1995 — J Biol Chem
Satellite Cell Activation 3.5× satellite cell proliferation vs. native IGF-1 at equal molar doses in human myoblasts. Foulstone EJ et al., 2003 — J Cell Physiol
Anti-Catabolism Significantly attenuated muscle protein catabolism and nitrogen loss in burn injury models. Herndon DN et al., 1999 — Ann Surg
Neuronal Survival Neurotrophic — extended half-life optimal for ALS, neuropathy and axonal regeneration models. Ishii DN et al., 1994

References

  1. Coleman ME et al. "Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy." J Biol Chem, 1995;270(20):12109–12116.
  2. LeRoith D et al. "The role of the insulin-like growth factor-I receptor in cancer." Ann N Y Acad Sci, 2003;995:58–68.
  3. Foulstone EJ et al. "Role of insulin-like growth factor binding protein-3 in the insulin-like growth factor axis of human skeletal muscle." J Cell Physiol, 2003;196(2):229–240.
  4. Singleton JR et al. "Insulin-like growth factor I signaling in motor neuron disease." Brain Res, 2000;888(2):241–248.

Specifications

Sequence
IGF-1 with N-terminal Met extension + Arg³ substitution
Molecular Weight
9117 Da
Amino Acids
83
Half-Life
20–30 hours
Vial Size
1mg
Purity
≥99% (HPLC)
Form
Lyophilized powder
Reconstitution
Bacteriostatic water (0.9% benzyl alcohol)
Storage
Sealed: 2–8 °C · Reconstituted: 2–8 °C, use within 28 days

Research library

Full mechanism breakdowns and peer-reviewed references for this compound.

Researcher reviews

4.8· 39 reviews

Frequently asked questions

Related research compounds

For laboratory and in-vitro research use only. Not for human or veterinary use, not for consumption. By purchasing, you confirm you are a qualified researcher and accept full responsibility for compliant handling and disposal. Read the full disclaimers.

≥99% HPLC Purity
3rd-Party Tested
EU Dispatched
Cold-Chain Shipping
COA Every Batch